Cochlear Limited was founded in Australia in 1981, based on Australian research by Dr Graeme Clark in developing the cochlear implant or bionic ear. By 2006 it had become an international leader in the manufacture and sale of cochlear implant systems.
This item is the first commercial model of a speech processor produced by Cochlear Limited. It was designed for use with the Nucleus 22 implant developed in 1983 which, in 1985, was the first multi-channel implant and speech processor system to receive approval for use by the US Food and Drug Administration.
This speech processor is the first of a number of generations of devices produced by Cochlear with continual improvements in sound processing and reduction in size. It represents Cochlear's design strategy of making a flexible cochlear implant with sophisticated sound processing in the externally worn speech processor, allowing the recipient to take advantage of improvements in technology without surgically replacing their implanted device.